"We are unsure of the ultimate significance of more than one negative CV signal, but it could put Celebrex on an even slipperier slope given the totality of CV findings across the entire COX-2 category of products, " Anderson wrote.

FORBES: Pfizer's Celebrex Risk Gets Worse